These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16166275)

  • 1. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.
    Emens LA; Jaffee EM
    Cancer Res; 2005 Sep; 65(18):8059-64. PubMed ID: 16166275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roadmap to a better therapeutic tumor vaccine.
    Emens LA
    Int Rev Immunol; 2006; 25(5-6):415-43. PubMed ID: 17169782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marrying immunotherapy with chemotherapy: why say IDO?
    Muller AJ; Prendergast GC
    Cancer Res; 2005 Sep; 65(18):8065-8. PubMed ID: 16166276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined chemoimmunotherapy of solid tumours: improving vaccines?
    Nowak AK; Lake RA; Robinson BW
    Adv Drug Deliv Rev; 2006 Oct; 58(8):975-90. PubMed ID: 17005292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy: friend or foe to cancer vaccines?
    Emens LA; Machiels JP; Reilly RT; Jaffee EM
    Curr Opin Mol Ther; 2001 Feb; 3(1):77-84. PubMed ID: 11249735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer vaccine development: on the way to break immune tolerance to malignant cells.
    Mocellin S; Rossi CR; Nitti D
    Exp Cell Res; 2004 Oct; 299(2):267-78. PubMed ID: 15350526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor resistance to CD8+ T cell-based therapeutic vaccination.
    Huang Y; Shah S; Qiao L
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):205-17. PubMed ID: 17659376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in therapeutic cancer vaccines.
    Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
    Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial cancer immunotherapy.
    Hodi FS; Dranoff G
    Adv Immunol; 2006; 90():341-68. PubMed ID: 16730268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence accumulating in support of cancer vaccines combined with chemotherapy: a pragmatic review of past and present efforts.
    Sinkovics JG; Horvath JC
    Int J Oncol; 2006 Oct; 29(4):765-77. PubMed ID: 16964374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to improve the immunogenicity of chemotherapy and radiotherapy.
    Ma Y; Conforti R; Aymeric L; Locher C; Kepp O; Kroemer G; Zitvogel L
    Cancer Metastasis Rev; 2011 Mar; 30(1):71-82. PubMed ID: 21298323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic cancer vaccines.
    Morris LF; Ribas A
    Surg Oncol Clin N Am; 2007 Oct; 16(4):819-31, ix. PubMed ID: 18022546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing cancer vaccine efficacy via modulation of the tumor microenvironment.
    Disis ML
    Clin Cancer Res; 2009 Nov; 15(21):6476-8. PubMed ID: 19861446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines.
    Mocellin S; Nitti D
    Med Res Rev; 2008 May; 28(3):413-44. PubMed ID: 17694549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy and tumor immunity: an unexpected collaboration.
    Emens LA
    Front Biosci; 2008 Jan; 13():249-57. PubMed ID: 17981543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells?
    Quesnel B
    Expert Rev Vaccines; 2006 Dec; 5(6):773-81. PubMed ID: 17184216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.